8-K: TRxADE Health Sells Web-Based Market Platform to Micro Merchant Systems for $22.5 Million

TRxADE Health, Inc. has agreed to sell its web-based market platform business to Micro Merchant Systems, Inc. for $22.5 million in cash, with a potential additional $7.5 million performance-based payment.

Summary

• TRxADE Health, Inc. has entered into an asset purchase agreement with Micro Merchant Systems, Inc. (MMS) to sell substantially all of the assets of its subsidiary, Trxade, Inc., which operates a web-based market platform for healthcare buyers and sellers.
• The purchase price is $22.5 million in cash, subject to adjustments for cash, debt, working capital, and transaction expenses.
• There is a potential additional payment of $7.5 million if MMS achieves certain collection targets within four months of closing, specifically $1.6 million or greater in collections from third parties.
• TRxADE Health will retain its pharmaceutical wholesale business through its subsidiary, Integra Pharma Solutions, LLC.
• The agreement includes customary representations, warranties, and covenants, including non-competition and non-solicitation clauses.
• MMS's recourse for post-closing indemnification claims is capped at 10% of the total purchase price, with customary exceptions.
• The transaction closed on February 16, 2024.

Sentiment

Score: 7

Explanation: The document indicates a strategic move by TRxADE Health to divest a non-core asset and focus on its wholesale business. The deal structure is reasonable, and the potential for an additional payment is positive. However, the loss of the market platform business is a negative.

Positives

• The sale provides TRxADE Health with a significant cash infusion of $22.5 million.
• The potential for an additional $7.5 million payment offers further upside.
• TRxADE Health retains its pharmaceutical wholesale business, allowing it to focus on a core area.
• The non-competition agreement protects the buyer's investment.

Negatives

• The sale means TRxADE Health is divesting its web-based market platform business.
• The additional $7.5 million payment is contingent on MMS achieving specific collection targets.
• The indemnification cap limits the buyer's recourse for certain claims.

Risks

• The additional $7.5 million payment is not guaranteed and depends on MMS's performance.
• The indemnification cap may limit MMS's ability to recover losses from certain breaches or inaccuracies.
• The transition of the business to MMS could present operational challenges.

Future Outlook

TRxADE Health will focus on its pharmaceutical wholesale business through Integra Pharma Solutions, while MMS will operate the acquired web-based market platform.

Management Comments

• The document does not contain any direct quotes from management, but it does outline the terms of the agreement and the future direction of the company.

Industry Context

This transaction reflects a trend of consolidation and strategic divestments in the healthcare technology sector, where companies are focusing on core competencies and seeking to optimize their portfolios.

Comparison to Industry Standards

• The deal structure, including a base purchase price with a performance-based earn-out, is common in acquisitions of technology businesses.
• The indemnification cap of 10% is within the typical range for similar transactions.
• The non-competition and non-solicitation clauses are standard for asset purchase agreements to protect the buyer's investment.
• Comparable companies in the healthcare technology space often engage in similar strategic transactions to streamline operations and focus on core business areas.

Stakeholder Impact

• Shareholders of TRxADE Health will benefit from the cash infusion and the company's focus on its core business.
• Employees of the web-based market platform business may transition to Micro Merchant Systems.
• Customers of the market platform will now be served by Micro Merchant Systems.
• Suppliers to the market platform will now be dealing with Micro Merchant Systems.

Next Steps

• TRxADE Health will continue to operate its pharmaceutical wholesale business through Integra Pharma Solutions.
• Micro Merchant Systems will integrate and operate the acquired web-based market platform.
• The parties will finalize post-closing adjustments to the purchase price.

Key Dates

Keywords

asset purchase, web-based market platform, pharmaceuticals, healthcare, acquisition, non-competition, indemnification, Trxade, Micro Merchant Systems, Integra Pharma Solutions